chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bells Palsy; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6200), dose 1 via an unspecified route of administration, administered in Arm Left on 22Feb2021 at 10:00 (at the age of 68-year-old) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication(s) included lisinopril 20 mg and atorvastatin 10 mg both were taken for an unspecified indication, start and stop date were not reported (Other medications in two weeks). Patient did not receive other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. Had no known allergies. Facility type vaccine: Doctor's office/urgent care. Other vaccine same date product: Pfizer COVID 19 vaccine, on 22Feb2021, dose number: 2 administered in Left arm. On 25Jul2021 21:00, patient experienced bells palsy. Patient visited Emergency room/department or urgent care for event. The patient underwent lab tests and procedures which included blood work, Ct scan and x-rays with unknown results on unspecified date. Therapeutic measures were taken as a result of bells palsy. The outcome of event was recovering.
The day of the vaccine, I just felt "off" for the rest of the day.  The initial symptoms started the next day and  were slight fever, fatigue and headache.  These symptoms resolved after a day and 1/2.   Then on 8/30/2021, I started having runny nose and sneezing and a little congestion.  These symptoms lasted for 12 days.  I did get a Covid test which came back negative on 9/9/2021.    Then the symptoms went away for about 8 days.  Then around 9/19/2021 evening, the symptoms came back- runny nose and sneezing.  By 9/21/2021, I felt better and symptoms had resolved.
Patient returned to clinic 2 days following immunization with left deltoid pain and redness at immunization site.  Patient diagnosed with cellulitis and treated with Keflex.
Information has been received from a health professional concerning a female patient who was not pregnant and who was vaccinated with a first 0.5 ml dose of HPV (lot # 653735/0688F). Initially the patient experienced numbness at the injection site immediately after administration of the vaccine which was followed by "tingling or prickly feeling" on arm of the injection site. The patient sought unspecified medical attention. The tingling or prickly feeling lasted for a period of 2 to 5 minutes and then totally went away. It was also reported that the patient recovered from numbness at the injection site. It was reported that 3 other female patient's had the same experience (WAES #'s 0610USA04385, 0610USA04386 and 0610USA03730). Additional information has been requested.  This is in follow-up to report (s) previously submitted on 11/14/2006.  Initial and follow up information has been received from a health professional concerning a female patient who was not pregnant and who was vaccinated with a first 0.5 ml dose of GARDASIL (lot # 653735/0688F).  Initially the patient experienced numbness at the injection site immediately after administration of the vaccine which was followed by "tingling or prickly feeling" on arm of the injection site.  The patient sought unspecified medical attention.  It was reported that the patient felt "right away" a numb feeling and then a tingling sensation down the arm.  The tingling or prickly feeling lasted for a period of 2 to 5 minutes and then totally went away.  It was also reported that the patient recovered from numbness at the injection site.  It was reported that 3 other female patient's had the same experience (WAES # WAES0610USA04385, WAES0610USA04386, and 0610USA03730).  Additional information is not expected.
H1N1 vaccine administered IM to left deltoid, within 30 seconds developed left arm itching, red face with bilateral eyelid swelling, tachycardia at 170 bpm, itching in the throat, abdominal cramping and aprehension. Benadryl 25mg IM adminstered, 911 call, child transported to ER by EMS in stable condition. Epi never given. 12/31/09:  Discharge summary and hospital records received for dates of service 12/29/09 to 12/30/09.  Dx:  Nonsustained tachycardia, resolved.  Likely anxiety attack.  Allergic reaction resolved.  Developed itchiness and redness at injection site, brought to ED for further evaluation and found to be tachycardic to 180.  Admitted to PICU for further management.  Anxiety noted with each episode of tachycardia.  EKG and Echo. Negative.  It was decided that tachycardia was due to anxiety and panic attacks, so patient was discharged to home after initiation of IV Solumedrol and transition to Orapred for treatment of allergic reaction.
Lightheadedness, dizziness, paresthesia of toes, fingers described as numbness.
Booster swelling lump and itchy red patch at site; Booster swelling lump and itchy red patch at site; Booster swelling lump and itchy red patch at site; warm to touch; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Nov2021 14:00 (Lot number: FC3527) at the age of 70 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "known allergies: Sulfa Drugs" (unspecified if ongoing); "Allergy: Penicillin" (unspecified if ongoing); "Allergy: Demerol" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D3 taken for vitamin d (ongoing); ZINC taken for vitamin c (ongoing). Vaccination history included: Bnt162b2 (Dose Number: 2, Lot number: EW0162, Anatomical location: Left arm), administration date: 12Apr2021, when the patient was 69 years old, for Covid-19 immunization, reaction(s): "sore arm"; Bnt162b2 (Dose Number: 1, Lot number: ER2613, Anatomical location: Left arm), administration date: 22Mar2021, when the patient was 69 years old, for Covid-19 immunization, reaction(s): "sore arm". The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 12Nov2021 20:00, outcome "recovering" and all described as "Booster swelling lump and itchy red patch at site". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site swelling, vaccination site pruritus.  Additional information: Facility type vaccine was Pharmacy or Drug Store. No other vaccine in four weeks. Other medications (Vitamin D3 and Zinc) was taken in two weeks. Booster swelling lump and itchy red patch at site. Started reaction in the evening on the 12th. Redness, itch, warm to touch, and swelling. No reaction for the two vaccines reaction just with the Booster.  No follow-up attempts are possible. No further information is expected.
Patient came to the pharmacy to complain. She told me that after she received the vaccination, her arm became swollen, warm and it hurt. She did what the immunizator pharmacist told her at the time of vaccination and it help her a little.
Dizziness for a full day. Extreme where I could not operate a vehicle or provide care for my children. It lasted for two days and gradually tapered off. This is not something that has ever happened before and no health problems and/or stressors or outside issues  are related to this experience.  I also have yet to have a period since obtaining the shot and I?m 45 days into my cycle that is always 28 days. There are no other explanations for this interruption. All pregnancy tests are negative and my husband has had a vasectomy.
The day after the vaccine I started spotting  and my back started getting numbness down my legs. I kept moving my legs because I was afraid I was going to lose feeling in them. I got an X-ray and it showed there is nothing wrong with my back and I concluded it has to be from the vaccine because it has resolved for the most part after 3 weeks. I was extremely fatigued for 3 days and my left cervical and right axillary lymph  nodes were swollen. I had a huge welt at the injection site for 2 weeks and now there?s still a bruise there. I am afraid to get my second vaccine because I don?t want to lose feeling in my legs. I need guidance from someone who knows a lot about this vaccine because no one is able to give me guidance.
Immediate swelling beneath ejection site in a 2 inch diameter. Slight redness, tender to touch.
1/31 10x10 cm circular erythematous ring w/ clear ctr on posterior aspect of R upper arm. Superior midline boarder in dry flaking area 2-3 cm (inject site). No inc in skin temp. Mild tenderness to palpatation. Second s/s slight erythema...
Noticed rash to trunk and facial skin, appeared like mosquito bites, about 2 weeks after taking the VZV vaccine.
Diarrhea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and HEADACHE (Headache). At the time of the report, DIARRHOEA (Diarrhea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
slight chills; slight soreness at injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 28Apr2021 18:00 (Lot number: EW0175) at the age of 46 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: NUTRAFOL taken for hair disorder, start date: Apr2021 (ongoing); PUMPKIN SEED OIL [CUCURBITA PEPO SEED OIL] taken for supplementation therapy, start date: Jan2021 (ongoing); KELP [MACROCYSTIS PYRIFERA] taken for supplementation therapy, start date: Aug2021 (ongoing); OCUVITE [ASCORBIC ACID;RETINOL;TOCOPHEROL] taken for supplementation therapy (ongoing); NIACINAMIDE taken for supplementation therapy, start date: May2021 (ongoing). Vaccination history included: Bnt162b2 (Dose 1, time: 18:15, Anatomical location: left Deltoid, route of administration: intramuscular, Batch/Lot No.: ER8729), administration date: 07Apr2021, when the patient was 46 years old, for Covid-19 Immunization, reaction(s): "slight soreness at injection site". The following information was reported: CHILLS (non-serious) with onset 2021, outcome "unknown", described as "slight chills"; VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "slight soreness at injection site". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, vaccination site pain.  Additional information: The first two doses had slight soreness at injection sight and 2nd dose had slight chills no other issues. Took no conmeds or treatment for it.    No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a medical assistant refers to a 15-month-old patient of unknown gender. No information on the patient's concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On 01-NOV-2016, the patient was vaccinated with improperly stored dose of VARIVAX injection (lot # M025867 with expiry date on 24-MAY-2018; dose and route of administration were not reported) for prophylaxis. The administered dose experienced a temperature excursion of 6.3 degrees Fahrenheit for 1 hour and 50 minutes, 6.6 degrees Fahrenheit for 1 hour and 40 minutes, 40.5 degrees Fahrenheit for 2 hours, 5.2 degrees Fahrenheit for 20 minutes and 6.3 degrees Fahrenheit for 1 hour and 50 minutes. Previous temperature excursion included 13.3 degrees Fahrenheit for 80 minutes and 9 degrees Fahrenheit for 420 minutes. Data logger was involved. No symptoms were reported. This is one of several cases received from the same reporter. Additional information is not expected as all relevant information has already been received. Sender's Comments: US-009507513-1610USA010748: US-009507513-1701USA000675: US-009507513-1701USA000676: US-009507513-1701USA000677: US-009507513-1701USA000678: US-009507513-1701USA000679: US-009507513-1610USA004609: US-009507513-1701USA000681: US-009507513-1701USA000682: US-009507513-1701USA000683: US-009507513-1701USA000684: US-009507513-1701USA000685: US-009507513-1701USA000686: US-009507513-1701USA000687: US-009507513-1701USA000688: US-009507513-1701USA000689: US-009507513-1701USA000690: US-009507513-1701USA000691: US-009507513-1701USA000692: US-009507513-1701USA000693: US-009507513-1701USA000694: US-009507513-1701USA000695: US-009507513-1701USA000696: US-009507513-1701USA000697: US-009507513-1701USA000698: US-009507513-1701USA000699: US-009507513-1701USA000700.
pt recv vax;HA, fever, hallucinations;w/in 12 hr muscle aches; nl LP, CT, Tox screen; pt slowly improving;
Intense pain in my shoulder, limited range of motion, tingling, pins and needles feeling. Radiating pain from my elbow, down my arm and into my hand, electrical shock feeling from my elbow down my arm and into my hand, numbness, soreness, and weakness.   I went to see Dr. who gave me an x-ray and told me to see a neurologist because she suspected nerve damage.   I went to see Dr. who performed several ncs tests on me and said in her report I have sirva. She also requested I take an mri which revealed I had bursitis and a tear in my rotator cuff, along with other findings. She recommended I go to physical therapy.   I am currently going to physical therapy. My doctor DPT, PT, OCS. I see him twice a week. My shoulder has improved but I still have pain when I lift my arm in certain directions and don?t have full range of motion. I have not fully recovered.
allergic reaction; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (allergic reaction) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced HYPERSENSITIVITY (allergic reaction). At the time of the report, HYPERSENSITIVITY (allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.
Nurse observed patient raising his hand in the post injection waiting area.  Patient appears to be paile. He was moved from the chair to the floow with lower extremeties fully elevated.  Patient lost consciousness for approximately 1-2 seconds. Regained consciousness following post vasovagal syncope. No injury occurred. Patient was coherent and aware of surroundings. BP 109/60. Pulse 68. Respirations 14. O2 sat 96%. Patient was moved via wheelchair to clinic for further observation . Hand over care to nurse.
Narrative: Symptoms:  Myalgia, Diarrhea & NauseaVomiting Treatment:
Body aches; injection site pain; low grade fever; This is a spontaneous report from a contactable consumer(patient). A 30-year-old male patient received second dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine), via an unspecified route of administration at left arm on 16Feb2021 10:00 at the 30 years old at single dose for COVID-19 immunization.  The medical history was not reported. The concomitant medications were Lisinopril and sertraline hydrochloride (ZOLOFT). The Historical Vaccine was first dose BNT162B2 on 26Jan2021 12:00 AM at 30 years old at Left arm for COVID-19 immunization. The patient experienced Body aches, injection site pain, and low-grade fever on 16Feb2021 22:00. There was no treatment received for all the adverse events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Fever, chills, headache, pain at injection site, injection site warm, tenderness in left arm pit
Myalgia, ErythemaMultiform, Injection site swelling, edema, fatigue Narrative: Pt experienced adverse event including injection site swelling, edema, erythema, fatigue and malaise 6 days after receiving vaccine
I starting had abdominal pain and diarrhea that lasted for for about 3 weeks. My heart was racing. I felt heart complication for about 5 days. I went to the doctor about it. They did an EKG, normal result. They did blood work, abnormal result. I also had a little bit of chest pain.
Onset on September 5, two days post vaccination of new form of seizures, with low grade fevers (to 102.5), dark brown urine, protein urine and hematuria, tachycardia (100) and yellow skin. Intractable seizures admitted x20 day so far.   10/29/2009 hospital records from multiple admissions 9/15-10/16/2009. Patient with sx of fever, tonic/clonic seizures, sore throat, dark urine, tacchycardia, cervical lymphadenopathy. Initially seen at PCP and tx'd for strep throat as rapid strep test was + although culture was negative. Sx progressed to tonic/clonic seizure activity of bilateral UE's up to 15 x a day. Patient evaluated per Pediatric Neurology.  10/30/09  Emergency Room records received for date of service 9/10/09.   Dx:  New onset Myoclonic Seizures, hematuria Assessment:  Presented to ED after 15 seizures a day over two days with gross hematuria that started two days prior.  Denied dysuria, abd. pain, polyuria, frequency or urgency.  Treated with Ativan.  Discharged to home in stable condition.   10/30/09 Discharge Summary and Medical Records received for dates of service 9/22/09 to 10/8/09.  Dx:  Myoclonic Seizure disorder, history of nephrolithasis secondary to hypocitraturia and hypercalcuria, gross hematuria, developmental delay including speech delay, scoliosis, growth hormone deficiency, failure to thrive, hypothyroidism, constipation.  Assessment:  Since having his flu shot, this child who has been maintained seizure free for two years on Keppra and a ketogenic diet had experienced tonic clonic activity, fevers and dark colored urine.  Presented for this hospitlalization after experiencing an apneic event which required for to five rescue breaths.  EEG was abnormal and pt. admitted.  Afebrile throughout stay with no evidence of rash.  Ketogenic diet was maintained.  New episode of hematuria with normal renal function, nromal blood pressure and no evidence of fluid retention. Hemoglobin remained stable during inpatient stay ranging from 12.5 o 13.3.   Electrolytes remained WNL.  Stable on room air. Transferred.    10/30/09 ICD 9 Codes Received:  345.11, 599.70, 783.40, 783.41, 244.9, 253.3, 315.39, 592.0, 737.30./rmc
Hives down neck, torso, arms and legs and face. Treated with Benadryl and prednisone.
Slight fever; fatigue; On the second day; Symptoms were resolved by the third day; No treatment--just rest on Day 2.
Pt was vaccinated at Conference room COVID19, with PfizerBionTech vaccine, Lot# EK 9231, at 1258 hours, while waiting in monitoring area, complained of rash and facial flush at 1305 hrs, initially given PO Benadryl by APP's at 50 mg for the rash and seen by me at 1306 hrs and got vitals. BP 160/110, HR 120 -130, SpO2 was 100% on room air, not complaining of shortness of breath, no stridor noted, tachycardia noted with regular rate and full bounding pulse, no wheezing noted bilateral lung fields, initiated early response call for eICU staff, also initiated potential call for inhouse and 911 call as back. At 1315 hours she had mild chest discomfort, tightness and felt dryness of throat. Rash not significantly visible on chest, facial flush present, decided to go ahead and gave epinephrine 0.3 mg IM to right deltoid as she was a unitard Stat suit. She was put on continuous monitoring, had response from eICU (Tele-ICU) team and Dr., SBP still noted to be elevated to 160's and DBP 110, Pulse still around 130, additionally IV access was secured, given IV Solumedrol 125 mg and IV Pepcid 20 mg. She felt somewhat better, still felt very anxious, with chest tightness, EMS on site by 1340 hrs and moved to ED by 1400 hrs, was with patient all through and transitioned to ED care To Dr. When last discussed her condition, was still stable noted at 1745 hrs in discussion with ED RN, with still persistently elevated BP and heart rate. No clear cut evidence for typical anaphylactic reaction. Treatment and observation still ongoing in ED.
1 cm x 1 cm nontender nodule at site of PEDIARIX injection on right upper thigh. That date PEDIARIX was administered was 2/25/11. The nodule appeared on 2/26/11.
Within 30-60 minutes of receiving vaccines, I broke out in rash and itched all over my body. I did not realize at first that this might be related to vaccine(s) and actually itched and scratched for 3 days before seeking medical attention. All other possible allergies were ruled out as nothing was different in diet, medications, soaps, etc, we attribute the reaction to the H1N1 since I have never before reacted to regular flu vaccines.
Chills; Fever; Pain at injection site; Diarrhea; Vomiting; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 13:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic constipation, depression, anxiety, sleep apnea and COVID-19 from an unknown date. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO) and macrogol 3350 (MIRALAX), both taken for an unspecified indication; ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for birth control, all from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 16:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 13Apr2021, the patient experienced chills, fever, pain at injection site, diarrhea, vomiting and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL EXTRA STRENGTH). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, pain at injection site, diarrhea, vomiting and muscle pain were not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.